{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-003855","form_type":"8-K","ticker":null,"cik":"0001305253","company_name":"Eiger BioPharmaceuticals, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.722968+00:00","generated_at":"2026-06-07T02:03:27.918914+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Eiger BioPharmaceuticals completes 1-for-30 reverse stock split effective Jan 5, 2024","bullets":["Reverse stock split ratio of 1:30 approved by stockholders on Dec 28, 2023 and Board.","Effective at 11:59 p.m. ET on Jan 5, 2024; stock began split-adjusted trading Jan 8, 2024.","No fractional shares issued; cash paid in lieu based on Nasdaq closing price prior to effective date.","New CUSIP number 28249U204 assigned to common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-003855","json":"https://secwatch.observer/filing/0001193125-24-003855.json","markdown":"https://secwatch.observer/filing/0001193125-24-003855.md","text":"https://secwatch.observer/filing/0001193125-24-003855.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1305253/000119312524003855/0001193125-24-003855-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1305253/000119312524003855/d111539d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:03:27.918914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"63208e8706243a2b26b968011647dca82fb1873c","claim":"Eiger BioPharmaceuticals, Inc.: Amended charter to effect a one-for-thirty reverse stock split (effective 2024-01-05).","evidence_excerpt":"On December 28, 2023, the Board approved the Reverse Stock Split at a ratio of one-for-thirty. Following such approval, the Company filed an amendment to its Charter (the “ Amendment ”) with the Secretary of State of the State of Delaware to effect the Reverse Stock Split, with an effective time of 11:59 p.m. Eastern Time on January 5, 2024 (the “ Effective Time ”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1305253/000119312524003855/0001193125-24-003855-index.htm","confidence":1.0,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-05"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}